175 related articles for article (PubMed ID: 33760988)
1. Disease spectrum of gastric cancer susceptibility genes.
McKinley SK; Singh P; Yin K; Wang J; Zhou J; Bao Y; Wu M; Pathak K; Mullen JT; Braun D; Hughes KS
Med Oncol; 2021 Mar; 38(5):46. PubMed ID: 33760988
[TBL] [Abstract][Full Text] [Related]
2. Penetrance of Gastric Adenocarcinoma Susceptibility Genes: A Systematic Review.
Hosseini S; Acar A; Sen M; Meeder K; Singh P; Yin K; Sutton JM; Hughes K
Ann Surg Oncol; 2023 Mar; 30(3):1795-1807. PubMed ID: 36528743
[TBL] [Abstract][Full Text] [Related]
3. Disease Spectrum of Breast Cancer Susceptibility Genes.
Wang J; Singh P; Yin K; Zhou J; Bao Y; Wu M; Pathak K; McKinley SK; Braun D; Hughes KS
Front Oncol; 2021; 11():663419. PubMed ID: 33959510
[TBL] [Abstract][Full Text] [Related]
4. Inherited Cancer Susceptibility Gene Sequence Variations Among Patients With Appendix Cancer.
Holowatyj AN; Washington MK; Tavtigian SV; Eng C; Horton C
JAMA Oncol; 2022 Nov; 9(1):95-101. PubMed ID: 36368039
[TBL] [Abstract][Full Text] [Related]
5. Heterozygous Pathogenic Nonsense Variant in the
Guadagnolo D; Mastromoro G; Marchionni E; Germani A; Libi F; Sadeghi S; Savio C; Petrucci S; De Marchis L; Piane M; Pizzuti A
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509701
[TBL] [Abstract][Full Text] [Related]
6. Genetic testing by cancer site: stomach.
Chun N; Ford JM
Cancer J; 2012; 18(4):355-63. PubMed ID: 22846738
[TBL] [Abstract][Full Text] [Related]
7. Genetic Gastric Cancer Susceptibility in the International Clinical Cancer Genomics Community Research Network.
Slavin T; Neuhausen SL; Rybak C; Solomon I; Nehoray B; Blazer K; Niell-Swiller M; Adamson AW; Yuan YC; Yang K; Sand S; Castillo D; Herzog J; Wu X; Tao S; Chavez T; Woo Y; Chao J; Mora P; Horcasitas D; Weitzel J
Cancer Genet; 2017 Oct; 216-217():111-119. PubMed ID: 29025585
[TBL] [Abstract][Full Text] [Related]
8. Non-medullary Thyroid Cancer Susceptibility Genes: Evidence and Disease Spectrum.
Zhou J; Singh P; Yin K; Wang J; Bao Y; Wu M; Pathak K; McKinley SK; Braun D; Lubitz CC; Hughes KS
Ann Surg Oncol; 2021 Oct; 28(11):6590-6600. PubMed ID: 33660127
[TBL] [Abstract][Full Text] [Related]
9. Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC).
Lo W; Zhu B; Sabesan A; Wu HH; Powers A; Sorber RA; Ravichandran S; Chen I; McDuffie LA; Quadri HS; Beane JD; Calzone K; Miettinen MM; Hewitt SM; Koh C; Heller T; Wacholder S; Rudloff U
J Med Genet; 2019 Jun; 56(6):370-379. PubMed ID: 30745422
[TBL] [Abstract][Full Text] [Related]
10. New germline mutations in BRCA1, ATM, MUTYH, and RAD51D genes in Tuvans early-onset breast cancer patients.
Gervas P; Molokov A; Ivanova A; Panferova Y; Kiselev A; Chernyshova A; Pisareva L; Choynzonov E; Cherdyntseva N
Exp Oncol; 2021 Mar; 43(1):52-55. PubMed ID: 33785725
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic Germline Mutations in Chinese Patients with Gastric Cancer Identified by Next-Generation Sequencing.
Zhou J; Zhao Z; Zhang Y; Bao C; Cui L; Cai S; Bai Y; Shen L; Zhang X
Oncology; 2020; 98(8):583-588. PubMed ID: 32521533
[TBL] [Abstract][Full Text] [Related]
12. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
Oliveira C; Ferreira P; Nabais S; Campos L; Ferreira A; Cirnes L; Alves CC; Veiga I; Fragoso M; Regateiro F; Dias LM; Moreira H; Suriano G; Machado JC; Lopes C; Castedo S; Carneiro F; Seruca R
Eur J Cancer; 2004 Aug; 40(12):1897-903. PubMed ID: 15288293
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of deleterious ATM germline mutations in gastric cancer patients.
Huang DS; Tao HQ; He XJ; Long M; Yu S; Xia YJ; Wei Z; Xiong Z; Jones S; He Y; Yan H; Wang X
Oncotarget; 2015 Dec; 6(38):40953-8. PubMed ID: 26506520
[TBL] [Abstract][Full Text] [Related]
14. Genetic predisposition to gastric cancer.
Petrovchich I; Ford JM
Semin Oncol; 2016 Oct; 43(5):554-559. PubMed ID: 27899187
[TBL] [Abstract][Full Text] [Related]
15. Germline pathogenic variant spectrum in 25 cancer susceptibility genes in Turkish breast and colorectal cancer patients and elderly controls.
Akcay IM; Celik E; Agaoglu NB; Alkurt G; Kizilboga Akgun T; Yildiz J; Enc F; Kir G; Canbek S; Kilic A; Zemheri E; Ezberci F; Ozcelik M; Dinler Doganay G; Doganay L
Int J Cancer; 2021 Jan; 148(2):285-295. PubMed ID: 32658311
[TBL] [Abstract][Full Text] [Related]
16. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.
Richards FM; McKee SA; Rajpar MH; Cole TR; Evans DG; Jankowski JA; McKeown C; Sanders DS; Maher ER
Hum Mol Genet; 1999 Apr; 8(4):607-10. PubMed ID: 10072428
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of the PREMMplus Model for Multigene Hereditary Cancer Risk Assessment.
Yurgelun MB; Uno H; Furniss CS; Ukaegbu C; Horiguchi M; Yussuf A; LaDuca H; Chittenden A; Garber JE; Syngal S
J Clin Oncol; 2022 Dec; 40(35):4083-4094. PubMed ID: 35960913
[TBL] [Abstract][Full Text] [Related]
18. The association between miR-146a gene rs2910164 polymorphism and gastric cancer risk: a meta-analysis.
Fu B; Song P; Lu M; Wang B; Zhao Q
Biomed Pharmacother; 2014 Oct; 68(8):923-8. PubMed ID: 25455160
[TBL] [Abstract][Full Text] [Related]
19. Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer Predisposition.
Tedaldi G; Pirini F; Tebaldi M; Zampiga V; Cangini I; Danesi R; Arcangeli V; Ravegnani M; Abou Khouzam R; Molinari C; Oliveira C; Morgagni P; Saragoni L; Bencivenga M; Ulivi P; Amadori D; Martinelli G; Falcini F; Ranzani GN; Calistri D
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31514334
[TBL] [Abstract][Full Text] [Related]
20. A new mutL homolog 1 c.1896+5G>A germline mutation detected in a Lynch syndrome-associated lung and gastric double primary cancer patient.
Chen X; Li X; Liang H; Wei L; Cui Q; Yao M; Wu X
Mol Genet Genomic Med; 2019 Aug; 7(8):e787. PubMed ID: 31207149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
